Fredrik Lehmann

1.4k total citations
59 papers, 1.1k citations indexed

About

Fredrik Lehmann is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Fredrik Lehmann has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 22 papers in Oncology and 14 papers in Organic Chemistry. Recurrent topics in Fredrik Lehmann's work include Multiple Myeloma Research and Treatments (12 papers), Peptidase Inhibition and Analysis (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Fredrik Lehmann is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Peptidase Inhibition and Analysis (10 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Fredrik Lehmann collaborates with scholars based in Sweden, United States and Finland. Fredrik Lehmann's co-authors include Joe Tiralongo, Evelin Tiralongo, Kristina Luthman, Johan Wennerberg, Jakob Lindberg, L Rondahl, J. Uppenberg, Thomas Lundbäck, Eva Axén and Stefan Svensson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Analytical Chemistry.

In The Last Decade

Fredrik Lehmann

59 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fredrik Lehmann Sweden 17 575 278 210 118 108 59 1.1k
Ramesh Ummanni India 25 756 1.3× 494 1.8× 167 0.8× 68 0.6× 90 0.8× 64 1.6k
Douglas R. Dougan United States 19 918 1.6× 378 1.4× 293 1.4× 219 1.9× 118 1.1× 32 1.6k
Giordana Feriotto Italy 23 1.1k 1.9× 166 0.6× 105 0.5× 68 0.6× 151 1.4× 93 1.6k
Karson S. Putt United States 21 699 1.2× 254 0.9× 413 2.0× 34 0.3× 214 2.0× 42 1.5k
Zanna Beharry United States 21 736 1.3× 217 0.8× 279 1.3× 81 0.7× 76 0.7× 33 1.3k
Jeffrey P. Krise United States 24 802 1.4× 241 0.9× 248 1.2× 33 0.3× 76 0.7× 37 1.6k
Laurie E. Grove United States 17 842 1.5× 102 0.4× 506 2.4× 111 0.9× 152 1.4× 35 1.6k
Matthew F. Brown United States 20 596 1.0× 198 0.7× 302 1.4× 118 1.0× 127 1.2× 38 1.5k
Danuta Duś Poland 23 776 1.3× 205 0.7× 378 1.8× 48 0.4× 327 3.0× 106 1.5k
John E. Kerrigan United States 24 1.2k 2.1× 355 1.3× 416 2.0× 44 0.4× 69 0.6× 53 2.0k

Countries citing papers authored by Fredrik Lehmann

Since Specialization
Citations

This map shows the geographic impact of Fredrik Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrik Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrik Lehmann more than expected).

Fields of papers citing papers by Fredrik Lehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredrik Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrik Lehmann. The network helps show where Fredrik Lehmann may publish in the future.

Co-authorship network of co-authors of Fredrik Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Fredrik Lehmann. A scholar is included among the top collaborators of Fredrik Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fredrik Lehmann. Fredrik Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guðjónsson, Þórarinn, Ari Jón Arason, Fredrik Lehmann, et al.. (2025). A novel macrolide, EP395, with reduced antibacterial activity and an enhancing effect on respiratory epithelial barrier. Pulmonary Pharmacology & Therapeutics. 90. 102363–102363. 1 indexed citations
2.
Lehmann, Fredrik, et al.. (2024). 18 F-labelling of nitrogen-containing aryl boronates – anti-cancer drug melflufen as a case study. Organic Chemistry Frontiers. 11(22). 6411–6417. 1 indexed citations
3.
Miettinen, Juho J., Toni-Karri Pakarinen, Mikko Manninen, et al.. (2022). Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen. Cells. 11(9). 1574–1574. 5 indexed citations
4.
Miettinen, Juho J., Romika Kumari, Gunnhildur Ásta Traustadóttir, et al.. (2021). Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen. Cancers. 13(7). 1527–1527. 39 indexed citations
5.
Byrgazov, Konstantin, Thomas Lind, Annica J. Rasmusson, et al.. (2021). Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes. Bone Reports. 15. 101098–101098. 3 indexed citations
6.
Kumari, Romika, Muntasir Mamun Majumder, Raija Silvennoinen, et al.. (2021). Prognostic significance of esterase gene expression in multiple myeloma. British Journal of Cancer. 124(8). 1428–1436. 28 indexed citations
7.
8.
Schepsky, Alexander, Gunnhildur Ásta Traustadóttir, Sævar Ingþórsson, et al.. (2020). Melflufen, a peptide‐conjugated alkylator, is an efficient anti‐neo‐plastic drug in breast cancer cell lines. Cancer Medicine. 9(18). 6726–6738. 9 indexed citations
9.
Kricker, Jennifer, Ari Jón Arason, Snævar Sigurðsson, et al.. (2020). Azithromycin ameliorates sulfur dioxide-induced airway epithelial damage and inflammatory responses. Respiratory Research. 21(1). 233–233. 17 indexed citations
10.
Lehmann, Fredrik, et al.. (2019). Application of triple quadrupole mass spectrometry for the characterization of antibody–drug conjugates. Analytical and Bioanalytical Chemistry. 411(12). 2569–2576. 8 indexed citations
11.
Artemenko, Konstantin A., et al.. (2018). Qualitative analysis of antibody–drug conjugates (ADCs): an experimental comparison of analytical techniques of cysteine-linked ADCs. The Analyst. 143(22). 5487–5496. 32 indexed citations
12.
Neupane, Rabin, et al.. (2017). Effect of mobile phase composition on the analysis of aggregates of antibody drug conjugates (ADCs) using size exclusion chromatography. Analytical Methods. 10(9). 938–941. 4 indexed citations
13.
Lehmann, Fredrik, Erika A. Currier, Roger Olsson, et al.. (2010). Optimization of isochromanone based urotensin II receptor agonists. Bioorganic & Medicinal Chemistry. 18(13). 4844–4854. 11 indexed citations
14.
Lehmann, Fredrik, Erika A. Currier, Bryan Clemons, et al.. (2009). Novel and potent small-molecule urotensin II receptor agonists. Bioorganic & Medicinal Chemistry. 17(13). 4657–4665. 6 indexed citations
15.
Barf, Tjeerd, Fredrik Lehmann, Kristin Hammer, et al.. (2009). N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(6). 1745–1748. 96 indexed citations
16.
Lehmann, Fredrik, Evelin Tiralongo, & Joe Tiralongo. (2006). Sialic acid-specific lectins: occurrence, specificity and function. Cellular and Molecular Life Sciences. 63(12). 1331–1354. 189 indexed citations
17.
Lehmann, Fredrik, Erika A. Currier, Roger Olsson, Uli Hacksell, & Kristina Luthman. (2005). Isochromanone-based urotensin-II receptor agonists. Bioorganic & Medicinal Chemistry. 13(8). 3057–3068. 26 indexed citations
18.
Lehmann, Fredrik. (2004). Evolution of sialic acid-binding proteins: molecular cloning and expression of fish siglec-4. Glycobiology. 14(11). 959–968. 33 indexed citations
19.
Lehmann, Fredrik, Eva Axén, J. Uppenberg, et al.. (2004). Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorganic & Medicinal Chemistry Letters. 14(17). 4445–4448. 71 indexed citations
20.
Lehmann, Fredrik, Åke Pilotti, & Kristina Luthman. (2003). Efficient large scale microwave assisted Mannich reactions using substituted acetophenones. Molecular Diversity. 7(2-4). 145–152. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramesh Ummanni Breakdown of academic impact, for papers by Douglas R. Dougan Breakdown of academic impact, for papers by Giordana Feriotto Breakdown of academic impact, for papers by Karson S. Putt Breakdown of academic impact, for papers by Zanna Beharry Breakdown of academic impact, for papers by Jeffrey P. Krise Breakdown of academic impact, for papers by Laurie E. Grove Breakdown of academic impact, for papers by Matthew F. Brown Breakdown of academic impact, for papers by Danuta Duś Breakdown of academic impact, for papers by John E. Kerrigan
Rankless by CCL
2026